NCT07102602

Brief Summary

Study Subjects: This study will recruit healthy males aged 18 to 35 who regularly exercise for at least 2.5 hours per week. Expected Number of Participants: 20. Methods and Procedures: This trial will be randomized into two groups, Groups A and B, who will undergo two isokinetic concentric exercise sessions (fatiguing exercise) separated by 15 days. Group A will first receive a fatigue prevention strategy (high-energy laser) followed by a placebo-controlled no-fatigue strategy 15 days later. Group B will first receive a placebo-controlled no-fatigue strategy followed by a fatigue prevention strategy (high-energy laser) 15 days later. The fatigue prevention strategy involves irradiating the quadriceps femoris with a 900-joule high-intensity laser therapy (3-watt output power for 5 minutes) before the isokinetic concentric exercise. The no-fatigue strategy (sham-controlled) involves irradiating the quadriceps femoris with a 0-joule high-energy laser (0-watt output power for 5 minutes) before the isokinetic concentric exercise. Muscle displacement, muscle excursion, as well as muscle electrophysiological changes, force output, and microcirculation parameters were measured before and after exercise to verify the feasibility of muscle displacement and migration for muscle fatigue assessment, and to further establish their impact and application value in muscle fatigue prevention strategies (high-intensity laser therapy).

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 30, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 31, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 4, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2025

Completed
Last Updated

August 4, 2025

Status Verified

July 1, 2025

Enrollment Period

3 months

First QC Date

July 31, 2025

Last Update Submit

July 31, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Muscle displacement

    pre-fatigue (baseline), immediately post-fatigue, 5, 10, 20 minutes post-fatigue

Study Arms (2)

high intensity laser therapy

ACTIVE COMPARATOR
Device: high intensity laser therapy

sham laser therapy

SHAM COMPARATOR
Device: Sham laser therapy

Interventions

The high-intensity laser used in this study is approved by the Ministry of Health and Welfare, Taiwan (No. 032670). It operates at a wavelength of 940 nm. For the active treatment (HILT), the laser delivers 900 joules to the quadriceps at a power output of 3 W for 5 minutes and is applied along the length of the quadriceps muscle

high intensity laser therapy

In the sham condition (SHAM), the output is set to 0 W for 5 minutes, resulting in no energy delivery.

sham laser therapy

Eligibility Criteria

Age18 Years - 35 Years
Sexmale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • healthy male aged between 18 and 35 years who engage in regular physical activity for at least 2.5 hours per week

You may not qualify if:

  • history of musculoskeletal injuries or lower limb muscle strains involving the dominant lower limb within the past six months
  • history of surgical interventions on the dominant lower limb

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University College of Medicine

Taipei, Taipei city, 100, Taiwan

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 31, 2025

First Posted

August 4, 2025

Study Start

November 30, 2024

Primary Completion

February 25, 2025

Study Completion

November 30, 2025

Last Updated

August 4, 2025

Record last verified: 2025-07

Locations